The authors discuss the therapeutic potential of p53-reactivating compounds with a particular focus on the pharmacological rescue of p53 in metastatic prostate cancer.
[European Journal of Pharmacology]
7992332
{7992332:AAAAAAAA}
apa
50
1
171983
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
